Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Randomized Trial of Vaccines for Zaire Ebola Virus Disease

2022; Massachusetts Medical Society; Volume: 387; Issue: 26 Linguagem: Inglês

10.1056/nejmoa2200072

ISSN

1533-4406

Autores

Mark Kieh, Laura Richert, Abdoul Habib Béavogui, Birgit Grund, Bailah Leigh, Éric D’Ortenzio, Seydou Doumbia, Edouard Lhomme, Samba O. Sow, Renaud Vatrinet, Céline Roy, Stephen B. Kennedy, Sylvain Landry Faye, Shelley Lees, Niouma Pascal Millimouno, Alseny Camara, Mohamed Samai, Gibrilla F. Deen, Moussa Doumbia, Hélène Esperou, Jérôme Pierson, Deborah Watson-Jones, Alpha Diallo, Deborah Wentworth, Chelsea McLean, Jakub K. Simon, Aurélie Wiedemann, Bonnie Dighero-Kemp, Lisa E. Hensley, H. Clifford Lane, Yves Lévy, Peter Piot, Brian Greenwood, Geneviève Chêne, James D. Neaton, Yazdan Yazdanpanah,

Tópico(s)

COVID-19 epidemiological studies

Resumo

Questions remain concerning the rapidity of immune responses and the durability and safety of vaccines used to prevent Zaire Ebola virus disease.

Referência(s)